Eszopiclone for the treatment of posttraumatic stress disorder and associated insomnia: A randomized, double-blind, placebo-controlled trial

Journal of Clinical Psychiatry

Volumn 72, Issue 7, 2011, Pages 892-897

  Pollack, Mark H ^a   Hoge, Elizabeth A ^a   Worthington, John J ^a   Moshier, Samantha J ^a   Wechsler, Rachel S ^a   Brandes, Mina ^a   Simon, Naomi M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESZOPICLONE; PLACEBO;

ADULT; ARTICLE; BEDTIME DOSAGE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSGEUSIA; FEMALE; HUMAN; INSOMNIA; MALE; OUTCOME ASSESSMENT; PITTSBURGH SLEEP QUALITY INDEX; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEDATION; SHORT PTSD RATING INTERVIEW; SIDE EFFECT; SLEEP QUALITY; TREATMENT DURATION;

ADULT; AMBULATORY CARE; AZABICYCLO COMPOUNDS; COMORBIDITY; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDDLE AGED; PERSONALITY ASSESSMENT; PIPERAZINES; PROSPECTIVE STUDIES; PSYCHOMETRICS; SLEEP INITIATION AND MAINTENANCE DISORDERS; STRESS DISORDERS, POST-TRAUMATIC; YOUNG ADULT;

EID: 79960728972     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.09m05607gry     Document Type: Article

References (50)

1. Kessler RC, Demler O, Frank RG, et al. Prevalence and treatment of mental disorders, 1990 to 2003. N Engl J Med. 2005;352(24):2515-2523. doi:10.1056/NEJMsa04326
2. Kessler RC, Sonnega A, Bromet E, et al. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry. 1995;52(12):1048-1060.
3. Boscarino JA. A prospective study of PTSD and early-age heart disease mortality among Vietnam veterans: implications for surveillance and prevention. Psychosom Med. 2008;70(6):668-676. doi:10.1097/PSY.0b013e31817bcaf
4. Nejad AG, Pouya F. Study on suicidality in veterans of Iraq-Iran war suffering from chronic PTSD. Eur Psychiatry. 2008;23(supp 2):S213. doi:10.1016/j.eurpsy.208.01.362
5. Maher MJ, Rego SA, Asnis GM. Sleep disturbances in patients with post-traumatic stress disorder: epidemiology, impact and approaches to management. CNS Drugs. 2006;20(7):567-590. doi:10.2165/023210-2062070-03 (Pubitemid 43990534)
6. Krakow B, Artar A, Warner TD, et al. Sleep disorder, depression, and suicidality in female sexual assault survivors. Crisis. 2000;21(4):163-170.
7. Saladin ME, Brady KT, Dansky BS, et al. Understanding comorbidity between PTSD and substance use disorders: two preliminary investigations. Addict Behav. 1995;20(5):643-655. doi:10.1016/0306-4603(95)024-7
8. Nishith P, Resick PA, Mueser KT. Sleep difficulties and alcohol use motives in female rape victims with posttraumatic stress disorder. J Trauma Stress. 2001;14(3):469-479. doi:10.1023/A:10152405048 (Pubitemid 32778067)
9. Krakow B, Melendrez D, Johnston L, et al. Sleep-disordered breathing, psychiatric distress, and quality of life impairment in sexual assault survivors. J Nerv Ment Dis. 2002;190(7):442-452. doi:10.1097/05053-202070-04 (Pubitemid 34815806)
10. Koren D, Arnon I, Lavie P, et al. Sleep complaints as early predictors of posttraumatic stress disorder: a 1-year prospective study of injured survivors of motor vehicle accidents. Am J Psychiatry. 2002;159(5):855-857. doi:10.176/api.ajp.159.5.85 (Pubitemid 34465062)
11. Harvey AG, Jones C, Schmidt DA. Sleep and posttraumatic stress disorder: a review. Clin Psychol Rev. 2003;23(3):377-407. doi:10.1016/S0272-7358(03)032-1 (Pubitemid 36506798)
12. Silvestri AJ. REM sleep deprivation affects extinction of cued but not contextual fear conditioning. Physiol Behav. 2005;84(3):343-349. doi:10.1016/j.physbeh.204.1.01 (Pubitemid 40342587)
13. Krystal AD, Walsh JK, Laska E, et al. Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, doubleblind, placebo-controlled study in adults with chronic insomnia. Sleep. 2003;26(7):793-799. (Pubitemid 39610622)
14. Zammit GK, McNabb LJ, Caron J, et al. Efficacy and safety of eszopiclone across 6-weeks of treatment for primary insomnia. Curr Med Res Opin. 2004;20(12):1979-1991. doi:10.185/174234304X15174 (Pubitemid 40179637)
15. Lieberman JA. Update on the safety considerations in the management of insomnia with hypnotics: incorporating modified-release formulations into primary care. Prim Care Companion J Clin Psychiatry. 2007;9(1):25-31. doi:10.408/PC.v09n0105
16. Fava M, McCall WV, Krystal A, et al. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Biol Psychiatry. 2006;59(11):1052-1060. doi:10.1016/j.biopsych.206.01.016 (Pubitemid 43849658)
17. Pollack M, Kinrys G, Krystal A, et al. Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder. Arch Gen Psychiatry. 2008;65(5):551-562. doi:10.101/archpsyc.65.5.51 (Pubitemid 351645051)
18. Connor KM, Davidson JR Jr. SPRINT: a brief global assessment of posttraumatic stress disorder. Int Clin Psychopharmacol. 2001;16(5):279-284. doi:10.1097/04850-201090-05 (Pubitemid 32822447)
19. Buysse DJ, Reynolds CF 3rd, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193-213. doi:10.1016/0165-1781(89)9047-4 (Pubitemid 19144991)
20. Blake DD, Weathers FW, Nagy LM, et al. The development of a Clinician-Administered PTSD Scale. J Trauma Stress. 1995;8(1):75-90. doi:10.102/jts.249080106
21. First M, Spitzer R, Gibbon M, et al. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition (SCID-I/NP). New York, NY: Biometrics Research, New York State Psychiatric Institute; 2002.
22. Hills M, Armitage P. The two-period cross-over clinical trial. Br J Clin Pharmacol. 1979;8(1):7-20. (Pubitemid 9234327)
23. Monti JM, Pandi-Perumal S. Eszopiclone: its use in the treatment of insomnia. Neuropsychiatr Dis Treat. 2007;3(4):441-453. (Pubitemid 350028009)
24. Kripke DF. Greater incidence of depression with hypnotic use than with placebo. BMC Psychiatry. 2007;7(1):42. doi:10.186/1471-24X-7-42
25. Scharf M. Eszopiclone for the treatment of insomnia. Expert Opin Pharmacother. 2006;7(3):345-356. doi:10.1517/1465656.7.3.345 (Pubitemid 43263251)
26. Rowlett J, Dunn J, Curry C, et al. Eszopiclone demonstrates anxiolyticlike activity in rhesus monkeys and healthy human volunteers at doses lower than those used to treat insomnia. Presented at the Annual Meeting of the American College of Neuropsychopharmacology, poster session; December 7-11, 2008; Scottsdale, Arizona.
27. Nutt D, Stahl SM. Searching for perfect sleep: the continuing evolution of GABA-A receptor modulators as hypnotics. J Psychopharmacol. 2010;24(11):1601-1612. doi:10.17/02698109106927
28. Jia F, Goldstein PA, Harrison NL. The modulation of synaptic GABA(A) receptors in the thalamus by eszopiclone and zolpidem. J Pharmacol Exp Ther. 2009;328(3):1000-1006. doi:10.124/jpet.108.146084
29. Yee BK, Hauser J, Dolgov VV, et al. GABA receptors containing the alpha5 subunit mediate the trace effect in aversive and appetitive conditioning and extinction of conditioned fear. Eur J Neurosci. 2004;20(7):1928-1936. doi:10.1/j.1460-9568.204.03642.x (Pubitemid 39471587)
30. Raskind MA, Peskind ER, Hoff DJ, et al. A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder. Biol Psychiatry. 2007;61(8):928-934. doi:10.1016/j.biopsych.206.06.032 (Pubitemid 46505008)
31. Krakow B, Hollifield M, Johnston L, et al. Imagery rehearsal therapy for chronic nightmares in sexual assault survivors with posttraumatic stress disorder: a randomized controlled trial. JAMA. 2001;286(5):537-545. doi:10.101/jama.286.5.537 (Pubitemid 33015238)
32. Lamarche LJ, De Koninck J. Sleep disturbance in adults with posttraumatic stress disorder: a review. J Clin Psychiatry. 2007;68(8):1257-1270. doi:10.408/JCP.v68n0813 (Pubitemid 47395629)
33. Stein DJ, Davidson J, Seedat S, et al. Paroxetine in the treatment of posttraumatic stress disorder: pooled analysis of placebo-controlled studies. Expert Opin Pharmacother. 2003;4(10):1829-1838. doi:10.1517/1465656.4.10.1829 (Pubitemid 37322367)
34. Davidson JR. Pharmacologic treatment of acute and chronic stress following trauma: 2006. J Clin Psychiatry. 2006;67(suppl 2):34-39. (Pubitemid 43268187)
35. Mayers AG, Baldwin DS. Antidepressants and their effect on sleep. Hum Psychopharmacol. 2005;20(8):533-559. doi:10.102/hup.726 (Pubitemid 43056116)
36. Argyropoulos SV, Wilson SJ. Sleep disturbances in depression and the effects of antidepressants. Int Rev Psychiatry. 2005;17(4):237-245. doi:10.1080/095402605010458 (Pubitemid 40942996)
37. Davidson J, Kudler H, Smith R, et al. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry. 1990;47(3):259-266. (Pubitemid 20086679)
38. Davidson JR, Weisler RH, Butterfield MI, et al. Mirtazapine vs placebo in posttraumatic stress disorder: a pilot trial. Biol Psychiatry. 2003;53(2):188-191. doi:10.1016/S06-323(02)0141-7 (Pubitemid 36126484)
39. Foa EB, Davidson JRT, Frances A. The Expert Consensus Guideline Series. Treatment of Posttraumatic Stress Disorder. The Expert Consensus Panels for PTSD. J Clin Psychiatry. 1999;60(suppl 16):3-76.
40. Warner MD, Dorn MR, Peabody CA. Survey on the usefulness of trazodone in patients with PTSD with insomnia or nightmares. Pharmacopsychiatry. 2001;34(4):128-131. doi:10.105/s-201-15871 (Pubitemid 32701761)
41. Mellman TA, Clark RE, Peacock WJ. Prescribing patterns for patients with posttraumatic stress disorder. Psychiatr Serv. 2003;54(12):1618-1621. doi:10.176/api.ps.54.12.1618 (Pubitemid 37486943)
42. Braun P, Greenberg D, Dasberg H, et al. Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment. J Clin Psychiatry. 1990;51(6):236-238. (Pubitemid 20209219)
43. Cates ME, Bishop MH, Davis LL, et al. Clonazepam for treatment of sleep disturbances associated with combat-related posttraumatic stress disorder. Ann Pharmacother. 2004;38(9):1395-1399. doi:10.1345/aph.1E043 (Pubitemid 39100190)
44. Stein MB, Kline NA, Matloff JL. Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study. Am J Psychiatry. 2002;159(10):1777-1779. doi:10.176/api.ajp.159.10.17
45. Rothbaum BO, Killeen TK, Davidson JR, et al. Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder. J Clin Psychiatry. 2008;69(4):520-525. doi:10.408/JCP.v69n0402 (Pubitemid 351792325)
46. Butterfield MI, Becker ME, Connor KM, et al. Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. Int Clin Psychopharmacol. 2001;16(4):197-203. doi:10.1097/04850-201070-03 (Pubitemid 32612517)
47. Dieperink ME, Drogemuller L. Zolpidem for insomnia related to PTSD. Psychiatr Serv. 1999;50(3):421.
48. Abramowitz EG, Barak Y, Ben-Avi I, et al. Hypnotherapy in the treatment of chronic combat-related PTSD patients suffering from insomnia: a randomized, zolpidem-controlled clinical trial. Int J Clin Exp Hypn. 2008;56(3):270-280. doi:10.1080/0207140802039672 (Pubitemid 351892493)
49. Sheehan D, Asnis G, Shrivastava R. Zolpidem extended-release 12.5 mg co-administered with escitalopram improves insomnia symptoms and next-day functioning in generalized anxiety disorder comorbid with chronic insomnia. Program and abstracts of the SLEEP 2008 22nd Annual Meeting of the Associated Professional Sleep Societies; June 7-12, 2008; Baltimore, Maryland.
50. Fava M, Asnis G, Shrivastava R, et al. Zolpidem extended-release, co-administered with escitalopram, improves insomnia in patients with comorbid insomnia and major depressive disorder. 161st Annual Meeting of the American Psychiatric Association; May 3-8, 2008; Washington, DC.